1 - 10 out of 16Page size: 10
  1. 2022

  2. Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer

    Dings, M. P. G., van der Zalm, A. P., Bootsma, S., van Maanen, T. F. J., Waasdorp, C., van den Ende, T., Liu, D., Bailey, P., Koster, J., Zwijnenburg, D. A., Spek, C. A., Klomp, J. P. G., Oubrie, A., Hooijer, G. K. J., Meijer, S. L., van Berge Henegouwen, M. I., Hulshof, M. C., Bergman, J., Oyarce, C., Medema, J. P., & 2 othersvan Laarhoven, H. W. M. & Bijlsma, M. F., 15 Nov 2022, In: Cell Reports Medicine. 3, 11, 100802.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer

    van Velzen, M. J. M., Creemers, A., van den Ende, T., Schokker, S., Krausz, S., Reinten, R. J., Dijk, F., van Noesel, C. J. M., Halfwerk, H., Meijer, S. L., Mearadji, B., Derks, S., Bijlsma, M. F. & van Laarhoven, H. W. M., Sep 2022, In: Gastric cancer. 25, 5, p. 906-915 10 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  4. 2021

  5. A systematic review of HER2 blockade for the curative treatment of gastroesophageal adenocarcinoma: Successes achieved and opportunities ahead

    Stroes, C. I., van den Ende, T., Derks, S. & van Laarhoven, H. W. M., 1 Sep 2021, In: Cancer treatment reviews. 99, 102249.

    Research output: Contribution to journal › Review article › Academic › peer-review

  6. Fecal microbiota transplantation from overweight or obese donors in cachectic patients with advanced gastroesophageal cancer: A randomized, double-blind, placebo-controlled, Phase II Study

    de Clercq, N. C., van den Ende, T., Prodan, A., Hemke, R., Davids, M., Pedersen, H. K., Nielsen, H. B., Groen, A. K., de Vos, W. M., van Laarhoven, H. W. M. & Nieuwdorp, M., 1 Jul 2021, In: Clinical cancer research. 27, 13, p. 3784-3792 9 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  7. Neoadjuvant chemoradiotherapy combined with atezolizumab for resectable esophageal adenocarcinoma: A single-arm phase ii feasibility trial (PERFECT)

    Van Den Ende, T., De Clercq, N. C., Van Berge Henegouwen, M. I., Gisbertz, S. S., Geijsen, E. D., Verhoeven, R. H. A., Meijer, S. L., Schokker, S., Dings, M. P. G., Bergman, J. J. G. H. M., Mohammad, N. H., Ruurda, J. P., Van Hillegersberg, R., Mook, S., Nieuwdorp, M., De Gruijl, T. D., Soeratram, T. T. D., Ylstra, B., Van Grieken, N. C. T., Bijlsma, M. F., & 2 othersHulshof, M. C. C. M. & Van Laarhoven, H. W. M., Jun 2021, In: Clinical cancer research. 27, 12, p. 3351-3359 9 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  8. 2020

  9. Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor types

    van den Ende, T., van den Boorn, H. C. G., Hoonhout, N. M., van Etten-Jamaludin, F. S., Meijer, S. L., Derks, S., de Gruijl, T. D., Bijlsma, M. F., van Oijen, M. G. H. & van Laarhoven, H. W. M., 1 Aug 2020, In: BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. 1874, 1, 188386.

    Research output: Contribution to journal › Review article › Academic › peer-review

  10. Gastro-oesophageal junction: to FLOT or to CROSS?

    van den Ende, T., Hulshof, M. C. C. M., van Berge Henegouwen, M. I., van Oijen, M. G. H. & van Laarhoven, H. W. M., 1 Feb 2020, In: Acta oncologica (Stockholm, Sweden). 59, 2, p. 233-236 4 p.

    Research output: Contribution to journal › Letter › Academic › peer-review

  11. 2019

  12. Immune checkpoints as promising targets for the treatment of idiopathic pulmonary fibrosis?

    Duitman, J. W., van den Ende, T. & Spek, C. A., Oct 2019, In: Journal of clinical medicine. 8, 10, 1547.

    Research output: Contribution to journal › Review article › Academic › peer-review

  13. Cutaneous Toxicity After Chemoradiotherapy and PD-L1 Inhibition in Two Patients with Esophageal Adenocarcinoma: More than Meets the Eye

    van den Ende, T., Menting, S. P., Ambarus, C. A., van Oijen, M. G. H. & van Laarhoven, H. W. M., Apr 2019, In: oncologist. 24, 4, p. e149-e153

    Research output: Contribution to journal › Article › Academic › peer-review

  14. COMplot, A Graphical Presentation of Complication Profiles and Adverse Effects for the Curative Treatment of Gastric Cancer: A Systematic Review and Meta-Analysis

    van den Ende, T., Abe Nijenhuis, F. A., van den Boorn, H. C. G., ter Veer, E., Hulshof, M. C. C. M., Gisbertz, S. S., van Oijen, M. G. H. & van Laarhoven, H. W. M., 2019, In: Frontiers in oncology. 9, 684.

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 1 2 Next

ID: 5169840